SCHEMBL6164555

SCHEMBL6164555

NC(=O)C1C(=O)CN1C(=O)[CH]Cc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
SIRT1 Q96EB6 1/20 0.34
CYP2C19 P33261 1/20 0.34
PARP2 Q9UGN5 3/20 0.34
GAA P10253 3/20 0.33
LMNA P02545 2/20 0.33
LTA4H P09960 1/20 0.33
TACR1 P25103 1/20 0.33
TNF P01375 1/20 0.32
STAT3 P40763 1/20 0.32
NOD2 Q9HC29 1/20 0.32
NOD1 Q9Y239 1/20 0.32
DPP4 P27487 1/20 0.32
FAP Q12884 1/20 0.32
DPP8 Q6V1X1 1/20 0.32
DPP9 Q86TI2 1/20 0.32
DPP7 Q9UHL4 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163684 0.86 SMN1; SMN2 (0.35) SMN1; SMN2SIRT1CYP2C19GAALMNA
SCHEMBL6052746 0.76 TACR1 (0.44) SMN1; SMN2CYP2C19GAALMNATACR1
SCHEMBL4086816 0.76 TACR1 (0.44) SMN1; SMN2CYP2C19GAALMNATACR1
SCHEMBL4095230 0.76 TACR1 (0.44) SMN1; SMN2CYP2C19GAALMNATACR1
SCHEMBL6164063 0.76 ACE (0.47)
SCHEMBL6704820 0.75 TACR1 (0.38) SMN1; SMN2SIRT1CYP2C19GAATACR1
SCHEMBL3094922 0.75 TACR1 (0.38) SMN1; SMN2SIRT1CYP2C19GAATACR1
SCHEMBL3138570 0.74 SPHK1 (0.50) DPP4DPP8DPP9DPP7
SCHEMBL6163349 0.74 PKM (0.34) SMN1; SMN2CYP2C19GAATACR1KMT2A
SCHEMBL3142015 0.73 FUCA1 (0.40) SMN1; SMN2SIRT1CYP2C19GAATACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
EP-0832065-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER INC. (US) 1998-04-01 EP disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed